Gonadal Hormones E2 and P Mitigate Cerebral Ischemia-Induced Upregulation of the AIM2 and NLRC4 Inflammasomes in Rats.
Animals
Apoptosis Regulatory Proteins
/ metabolism
Astrocytes
/ metabolism
Brain
/ metabolism
Brain Ischemia
/ metabolism
DNA-Binding Proteins
/ metabolism
Estradiol
/ metabolism
Gonadal Hormones
/ metabolism
Infarction, Middle Cerebral Artery
/ metabolism
Inflammasomes
/ metabolism
Male
Microglia
/ metabolism
Neurons
/ metabolism
Rats
Rats, Wistar
Receptors, Cell Surface
/ metabolism
Reperfusion
/ methods
Stroke
/ metabolism
Up-Regulation
/ physiology
AIM
Astrocytes
Estrogen
Inflammasomes
Microglia
NLRC4
Neuroprotection
OGD
Progesterone
Stroke
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
07 Jul 2020
07 Jul 2020
Historique:
received:
15
06
2020
revised:
01
07
2020
accepted:
03
07
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
18
2
2021
Statut:
epublish
Résumé
Acute ischemic stroke (AIS) is a devastating neurological condition with a lack of neuroprotective therapeutic options, despite the reperfusion modalities thrombolysis and thrombectomy. Post-ischemic brain damage is aggravated by an excessive inflammatory cascade involving the activation and regulation of the pro-inflammatory cytokines IL-1β and IL-18 by inflammasomes. However, the role of AIM2 and NLRC4 inflammasomes and the influence of the neuroprotective steroids 17β-estradiol (E2) and progesterone (P) on their regulation after ischemic stroke have not yet been conclusively elucidated. To address the latter, we subjected a total of 65 rats to 1 h of transient Middle Cerebral Artery occlusion (tMCAO) followed by a reperfusion period of 72 h. Moreover, we evaluated the expression and regulation of AIM2 and NLRC4 in glial single-cell cultures (astroglia and microglia) after oxygen-glucose deprivation (OGD). The administration of E2 and P decreased both infarct sizes and neurological impairments after cerebral ischemia in rats. We detected a time-dependent elevation of gene and protein levels (Western Blot/immunohistochemistry) of the AIM2 and NLRC4 inflammasomes in the post-ischemic brains. E2 or P selectively mitigated the stroke-induced increase of AIM2 and NLRC4. While both inflammasomes seemed to be exclusively abundant in neurons under physiological and ischemic conditions in vivo, single-cell cultures of cortical astrocytes and microglia equally expressed both inflammasomes. In line with the in vivo data, E and P selectively reduced AIM2 and NLRC4 in primary cortical astrocytes and microglial cells after OGD. In conclusion, the post-ischemic elevation of AIM2 and NLRC4 and their down-regulation by E2 and P may shed more light on the anti-inflammatory effects of both gonadal hormones after stroke.
Identifiants
pubmed: 32645874
pii: ijms21134795
doi: 10.3390/ijms21134795
pmc: PMC7370209
pii:
doi:
Substances chimiques
AIM2 protein, rat
0
Apoptosis Regulatory Proteins
0
DNA-Binding Proteins
0
Gonadal Hormones
0
Inflammasomes
0
NLRC4 protein, rat
0
Receptors, Cell Surface
0
Estradiol
4TI98Z838E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medizinische Fakultät, RWTH Aachen University
ID : START 24/15
Références
Inflamm Res. 2009 Sep;58(9):619-24
pubmed: 19333725
Exp Neurol. 2014 Jul;257:114-9
pubmed: 24805069
J Steroid Biochem Mol Biol. 2012 Aug;131(1-2):10-6
pubmed: 22326729
Nat Rev Neurosci. 2014 Feb;15(2):84-97
pubmed: 24399084
J Neuroimmunol. 2015 Jan 15;278:200-11
pubmed: 25468770
Brain Behav Immun. 2017 Nov;66:177-192
pubmed: 28648389
Neuroendocrinology. 2016;103(5):460-75
pubmed: 26337121
J Steroid Biochem Mol Biol. 2017 Mar;167:126-134
pubmed: 27884727
Brain Behav Immun. 2020 Jul;87:765-776
pubmed: 32201254
Sci Rep. 2018 Apr 13;8(1):5971
pubmed: 29654318
J Steroid Biochem Mol Biol. 2013 Nov;138:195-205
pubmed: 23792783
J Cereb Blood Flow Metab. 2011 Apr;31(4):991-3
pubmed: 21206507
Ageing Res Rev. 2013 Sep;12(4):941-66
pubmed: 24103368
Brain Behav Immun. 2011 May;25(4):715-26
pubmed: 21277368
Neurobiol Aging. 2014 Feb;35(2):309-21
pubmed: 24054992
Mol Neurobiol. 2020 Jun;57(6):2588-2599
pubmed: 32239449
Stroke. 1995 Apr;26(4):627-34; discussion 635
pubmed: 7709410
J Steroid Biochem Mol Biol. 2018 Oct;183:18-26
pubmed: 29772377
Exp Neurol. 2005 Jun;193(2):522-30
pubmed: 15869954
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4050-5
pubmed: 25775556
J Neuroimmunol. 2017 Sep 15;310:107-110
pubmed: 28778433
Neural Regen Res. 2019 Mar;14(3):542-552
pubmed: 30539825
Stroke. 2015 Aug;46(8):2341-6
pubmed: 26152294
Exp Neurol. 2020 Mar;325:113139
pubmed: 31794744
J Mol Neurosci. 2014 Feb;52(2):277-85
pubmed: 24163150
Oxid Med Cell Longev. 2018 Apr 18;2018:4248526
pubmed: 29849895
J Drug Target. 2019 Sep;27(8):866-875
pubmed: 30601069
Glia. 2015 May;63(5):812-25
pubmed: 25627810
Cell Death Dis. 2013 Sep 05;4:e790
pubmed: 24008734
Int J Mol Sci. 2020 May 26;21(11):
pubmed: 32466385
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
Clin Neurol Neurosurg. 2009 Jul;111(6):483-95
pubmed: 19446389
Brain Res Mol Brain Res. 2005 Jul 29;138(1):1-7
pubmed: 15896872
J Cereb Blood Flow Metab. 2014 Apr;34(4):660-7
pubmed: 24424382
Biosci Rep. 2019 Jan 8;39(1):
pubmed: 30373775
Neuromolecular Med. 2019 Sep;21(3):275-286
pubmed: 31218587
J Mol Neurosci. 2011 Mar;43(3):268-74
pubmed: 20607446
Brain Behav Immun. 2019 Jan;75:34-47
pubmed: 30195027
Mol Med Rep. 2019 May;19(5):3555-3563
pubmed: 30864712
FASEB J. 2020 Jan;34(1):648-662
pubmed: 31914678
J Neuroinflammation. 2020 Feb 1;17(1):45
pubmed: 32007102
Cell Immunol. 2015 Apr;294(2):63-9
pubmed: 25682174
Stroke. 2019 May;50(5):1232-1239
pubmed: 31009361
Int J Stroke. 2019 Aug;14(6):574-591
pubmed: 30940045
EMBO Mol Med. 2020 Apr 7;12(4):e11002
pubmed: 32239625
Biochem Biophys Res Commun. 2019 Apr 2;511(2):468-475
pubmed: 30797557
Front Cell Neurosci. 2014 Aug 01;8:216
pubmed: 25136295
Neuroendocrinology. 2014;99(3-4):156-67
pubmed: 24685982
J Exp Med. 2017 May 1;214(5):1351-1370
pubmed: 28404595